Hypnotherapy as an adjuvant for the management of inflammatory bowel disease: A case report

被引:11
|
作者
Emami, Mohammad Hassan [2 ,3 ]
Gholamrezaei, Ali [1 ,3 ]
Daneshgar, Houshang [1 ,2 ]
机构
[1] Poursina Hakim Res Inst, Esfahan, Iran
[2] Isfahan Univ Med Sci, Dept Gastroenterol, Esfahan, Iran
[3] Isfahan Univ Med Sci, Med Student Res Comm, Clin Hypnotherapy Res Grp, Esfahan, Iran
关键词
Inflammatory bowel disease; Crohn's disease; hypnotherapy; complementary; psychological; coping; quality of life; QUALITY-OF-LIFE; IBS-LIKE SYMPTOMS; ULCERATIVE-COLITIS; GASTROINTESTINAL-TRACT; HYPNOSIS; STRESS; IMPACT; REMISSION; IMMUNITY; PROGRAM;
D O I
10.1080/00029157.2009.10401675
中图分类号
B849 [应用心理学];
学科分类号
040203 ;
摘要
Idiopathic inflammatory bowel diseases (IBDs) significantly affect the quality of life of sufferers. Improved quality of life and patient symptom management may be achieved through integrating psychological/behavioral interventions with pharmacologic treatments. Here is our experience with hypnotherapy as an adjuvant management for an 18-year-old female with Crohn's Disease (CD) in remission (patient I) and a 24-year-old female with CD in active phase (patient II). The patients participated in 12 weekly one-hour sessions of hypnotherapy. Gut-directed, ego-strengthening, and post-hypnotic suggestions and immune-directed imaginations were used. After the hypnotherapy course, symptoms, psychological state, and quality of life improved in patient I, but not patient It (according to questionnaires). After a 6 month follow-up, symptoms and quality of life were the same as at the end of hypnotherapy sessions in both patients. The patients reported the greatest benefit of hypnotherapy was in helping them to cope better with their disease and also in improving their psychological state. Hypnotherapy may improve quality of life of IBD patients in remission and help them to cope better with their disease. Well-designed controlled clinical trials are needed in this field.
引用
收藏
页码:255 / 262
页数:8
相关论文
共 50 条
  • [1] Treatment of inflammatory bowel disease: A role for hypnotherapy?
    Miller, Vivien
    Whorwell, Peter J.
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL HYPNOSIS, 2008, 56 (03) : 306 - 317
  • [2] Hypnotherapy for Inflammatory Bowel Disease Across the Lifespan
    Szigethy, Eva
    AMERICAN JOURNAL OF CLINICAL HYPNOSIS, 2015, 58 (01) : 81 - 99
  • [3] Treatment of inflammatory bowel disease: A role for hypnotherapy?
    Whorwell, Peter
    AMERICAN JOURNAL OF CLINICAL HYPNOSIS, 2008, 51 (02) : 222 - 223
  • [4] Adjuvant therapy with antidepressants for the management of inflammatory bowel disease
    Mikocka-Walus, Antonina
    Prady, Stephanie L.
    Pollok, Justyna
    Esterman, Adrian J.
    Gordon, Andrea L.
    Knowles, Simon
    Andrews, Jane M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2019, (04):
  • [5] Inflammatory bowel disease - case report
    Herrlinger, K
    Stange, EF
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2004, 129 (42) : 2243 - 2243
  • [6] Review article: gut-directed hypnotherapy in the management of irritable bowel syndrome and inflammatory bowel disease
    Peters, S. L.
    Muir, J. G.
    Gibson, P. R.
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2015, 41 (11) : 1104 - 1115
  • [7] Case Report: Inflammatory Bowel Disease and Thrombosis
    Maneval, Rhonda E.
    Clemence, Bonnie J.
    JOURNAL OF INFUSION NURSING, 2016, 39 (03) : 151 - 157
  • [8] Histoplasmosis and inflammatory bowel disease: A case report
    Dahiya, Dushyant
    Kichloo, Asim
    Singh, Jagmeet
    Albosta, Michael
    Wani, Farah
    WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY, 2021, 13 (01): : 24 - 32
  • [9] Dorsal Root Ganglion Stimulation for the Management of Inflammatory Bowel Disease: A Case Report
    Yang, Ajax
    Yousef, Tariq A.
    Aggarwal, Nitish
    Chapman, Kenneth B.
    A & A PRACTICE, 2024, 18 (06) : e01804
  • [10] Case Report: Inflammatory Myositis in Association with Inflammatory Bowel Disease
    Abhijit Kulkarni
    T. Jan Ravi
    George J. Brodmerkel
    Radheshyam M. Agrawal
    Digestive Diseases and Sciences, 1997, 42 : 1142 - 1145